01:46:10 EDT Mon 10 May 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for U:AXNX from 2020-05-11 to 2021-05-10 - 37 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2021-05-06 16:01U:AXNXNews ReleaseAxonics ® Reports First Quarter 2021 Financial Results
2021-04-22 06:00U:AXNXNews ReleaseAxonics ® to Participate in the BofA Securities 2021 Virtual Healthcare Conference
2021-04-15 06:00U:AXNXNews ReleaseAxonics ® to Report First Quarter 2021 Financial Results on May 6, 2021
2021-03-03 06:00U:AXNXNews ReleaseAxonics ® to Participate in the Barclays Global Healthcare Conference
2021-03-02 07:55U:AXNXNews ReleaseEndotronix Appoints Industry Veteran Dan Dearen to Board of Directors
2021-03-02 06:00U:AXNXNews ReleaseAxonics ® Announces Strategic Alliance for the Manufacture of New Non-Rechargeable Implantable Sacral Neuromodulation Device
2021-02-25 16:05U:AXNXNews ReleaseAxonics ® Reports Fourth Quarter and Fiscal Year 2020 Results
2021-02-25 16:01U:AXNXNews ReleaseAxonics ® Expands into Stress Urinary Incontinence with the Acquisition of Bulkamid ®
2021-02-22 16:01U:AXNXNews ReleaseAxonics ® to Report Fourth Quarter and Fiscal Year 2020 Financial Results on February 25, 2021
2021-02-18 06:00U:AXNXNews ReleaseAxonics ® to Participate in the Society for Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction 2021 Winter Meeting
2021-02-16 06:00U:AXNXNews ReleaseAxonics ® Receives FDA Approval for Third-Generation Implantable Neurostimulator
2021-02-11 06:00U:AXNXNews ReleaseAxonics ® to Participate in the SVB Leerink Global Healthcare Conference
2021-01-25 16:01U:AXNXNews ReleaseAxonics ® Reports Preliminary Fourth Quarter and Fiscal Year 2020 Revenue
2020-12-14 08:00U:AXNXNews ReleaseAxonics ® Announces Appointment of David M. Demski to Board of Directors
2020-11-19 06:00U:AXNXNews ReleaseAxonics ® to Participate in Piper Sandler Virtual Healthcare Conference
2020-11-10 06:00U:AXNXNews ReleaseAxonics ® Announces Publication of Fecal Incontinence Study Results for Patients Treated with r-SNM ® System
2020-11-04 16:00U:AXNXNews ReleaseAxonics ® Reports Third Quarter 2020 Results
2020-10-29 06:00U:AXNXNews ReleaseAxonics ® Submits PMA Supplement to FDA to Further Expand MRI Labeling
2020-10-20 08:00U:AXNXNews ReleaseAxonics ® Launches ARTISTRY Study to Collect and Analyze Real-World Data of Patients Implanted with the Axonics r-SNM System
2020-10-14 06:00U:AXNXNews ReleaseAxonics ® to Report Third Quarter 2020 Results on November 4
2020-10-07 16:00U:AXNXNews ReleaseAxonics ® CEO Raymond W. Cohen Named Ernst & Young Entrepreneur of the Year ® 2020 Award Winner for Orange County
2020-10-05 08:00U:AXNXNews ReleaseAxonics ® Announces Survey Results of Patients Treated with the Axonics r-SNM System That Were Previously Implanted with InterStim II
2020-09-24 06:00U:AXNXNews Release  Axonics ® Provides Update on Inter Partes Review Proceedings
2020-09-23 07:00U:AXNXNews ReleaseLongitude Capital Raises $585 Million Fund to Invest in Transformative Healthcare Companies
2020-09-16 09:00U:AXNXNews ReleaseAxonics ® CEO Raymond W. Cohen Named Ernst & Young Entrepreneur of the Year ® 2020 Award Finalist for Orange County
2020-09-10 06:00U:AXNXNews ReleaseAxonics ® Reports 2-Year Clinical Results from ARTISAN-SNM Pivotal Study
2020-09-08 08:30U:AXNXNews ReleaseNICE Recommends Axonics ® r-SNM System for Treating Overactive Bladder
2020-09-03 06:00U:AXNXNews ReleaseAxonics ® to Participate in Upcoming Investor Conferences
2020-09-02 10:00U:AXNXNews ReleaseAxonics ® to Host Presentation of Full 2-Year Clinical Results from ARTISAN-SNM Pivotal Study on September 9
2020-08-06 16:00U:AXNXNews ReleaseAxonics ® Reports Second Quarter 2020 Results
2020-07-27 06:00U:AXNXNews ReleaseAxonics ® Announces 2-Year Topline Clinical Results from ARTISAN-SNM Pivotal Study
2020-07-16 06:00U:AXNXNews ReleaseAxonics ® to Report Second Quarter 2020 Results on August 6
2020-07-13 06:00U:AXNXNews ReleaseAxonics ® Reports Preliminary Second Quarter 2020 Revenue
2020-07-01 16:00U:AXNXNews ReleaseAxonics ® Receives FDA Approval for 3T Full-Body MRI Scans
2020-06-03 06:00U:AXNXNews ReleaseAxonics ® Announces U.S. Food & Drug Administration Approval of Wireless Patient Remote Control with SmartMRI Technology
2020-05-19 06:00U:AXNXNews ReleaseAxonics ® ARTISAN Results Published Demonstrating Continued Therapy Response and Patient Satisfaction at 1-year
2020-05-12 16:05U:AXNXNews ReleaseAxonics ® Announces Closing of Public Stock Offering and Full Exercise of Underwriters ’ Option to Purchase Additional Stock